Immunostics offers a broad portfolio of performance driven diagnostics solutions that provide more effective ways to assist in the diagnosis of disease.
At a Glance
Immunostics offers a broad portfolio of performance-driven diagnostics solutions that provide more effective ways to assist in the diagnosis of disease. Our products offer the right balance of science, technology and practicality across the healthcare continuum to provide healthcare professionals with the vital information they need to deliver better, more personalized healthcare to patients around the globe.
The company's commitment to innovation continues today with a substantial development program focused on these fields. Immunostics products are FDA cleared, CLIA waived and have received strong endorsements from both clinicians and medical product distributors. We wish to extend thanks to our many domestic and international distribution partners as well as to the clinicians, and patients who are the ultimate consumers of our products.
Mr. Kenneth Kupits and Mr. Vincent LaStella founded Immunostics, Inc. in 1983 in Metuchen, NJ to provide clinical laboratories with quality microbiological, serological and immunological reagents and in vitro diagnostic test kits. Working closely with a community of professionals highly skilled in the design and development of diagnostic reagents and testing formats, Immunostics has become a recognized leader in developing innovative and cost effective test systems world wide.
Our product line includes over 30 products in four clinical areas: pregnancy testing, infectious and autoimmune testing, fecal occult blood testing (iFOBT and FOBT) and direct bacterial identification systems. Messrs. Kupits and LaStella were the originators of the first fecal occult blood slide test, Hemocult, which was eventually sold to Smith Kline. Immunostics has enjoyed significant growth over the years through timely and innovative product developments.